Victory Capital Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
254,770
+21,787
| +9% | +$946K | 0.01% | 1077 |
|
|
2025
Q1 | $8.7M | Buy |
232,983
+9,921
| +4% | +$371K | 0.01% | 1107 |
|
|
2024
Q4 | $10.1M | Sell |
223,062
-123,296
| -36% | -$5.59M | 0.01% | 1086 |
|
|
2024
Q3 | $20.3M | Buy |
346,358
+190,092
| +122% | +$11.2M | 0.02% | 842 |
|
|
2024
Q2 | $6.15M | Buy |
156,266
+56,607
| +57% | +$2.23M | 0.01% | 1205 |
|
|
2024
Q1 | $6.62M | Buy |
99,659
+83,839
| +530% | +$5.57M | 0.01% | 1169 |
|
|
2023
Q4 | $442K | Hold |
15,820
| – | – | ﹤0.01% | 2028 |
|
|
2023
Q3 | $337K | Buy |
+15,820
| New | +$337K | ﹤0.01% | 2088 |
|